drugset / Trial / NCT02685150

Endoscopic Tri-Modal Imaging to Distinguish Functional Dyspepsia From Reflux Disease

NCT02685150

Completed 157 enrolled Chinese PLA General Hospital
Non-randomizedParallel-groupOpen-labelDiagnostic

Summary

Endoscopic Tri-Modal Imaging which combines Narrow-band Imaging(NBI), Autofluorescence Imaging (AFI) and White-light Imaging (WLI) could be used to identify the indistinct changes in the gut caused by reflux disease,either acid reflux or bile reflux, which make it possible to differentiate reflux disease from functional dyspepsia (FD).

Timeline

Start
2016-01
Primary completion
2018-06
Completion
2018-06

Drugs

EvaluationDrugModalityDoseRoute
Background Omeprazole Other / unclassified 20 mg